ERBB2 and breast cancer: Specifically, the authors have demonstrated that MKK7 is required for tumor suppression and overall survival using two different tumor models: KRasG12D-driven lung carcinomas and HER2/Neu (NeuT) oncogene-driven mammary tumors.